Profile
ASRT ZTS HLN TAK TEVA ITCI
Company Name Assertio Holdings, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $77.60M $71.85B $45.63B $44.07B $18.79B $13.67B
Employees 0.05K 13.80K 25.41K 49.28K 33.89K 0.86K
CEO Mr. Brendan P. O'Grady Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
ASRT ZTS HLN TAK TEVA ITCI
Quant Rating Score 2 3 3 3 1 1
Quant Rating Sell Neutral Neutral Neutral Strong Sell Strong Sell
Trading
ASRT ZTS HLN TAK TEVA ITCI
Last Close $0.797 $165.31 $10.15 $14.08 $16.78 $128.57
High 52 $1.75 $199.94 $10.69 $15.08 $22.77 $128.61
Low 52 $0.75 $145.54 $8.01 $12.6 $12.78 $64.37
Price vs. 52 Week High -54.46 % -17.32 % -5.05 % -6.63 % -26.31 % -0.03 %
Price vs. 52 Week Low 6.27 % 13.58 % 26.72 % 11.75 % 31.3 % 99.74 %
Total Return
ASRT ZTS HLN TAK TEVA ITCI
1 Month Return -5.46 % -1.96 % 8.09 % 8.39 % -22.6 % 0.96 %
3 Month Return -21.09 % -7.5 % 5.95 % 4.37 % 0.54 % 51.28 %
6 Month Return -37.73 % -8.62 % 2.53 % -6.63 % -9.59 % 72.62 %
9 Month Return -20.3 % -2.8 % 21.12 % 7.32 % 1.08 % 96.17 %
YTD Return -8.51 % 1.46 % 6.39 % 6.34 % -23.87 % 53.94 %
1 Year Return -2.8 % -16.18 % 20.69 % -3.69 % 30.18 % 83.25 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ASRT ZTS HLN TAK TEVA ITCI
Dividend Yield Percentage (TTM) - 1.12 % 0.02 % 4.59 % - -
Dividend Paid and Capex Coverage Ration (TTM) 114.26 % 2.05 % - 1.76 % 2.5 % -82.88 %
Dividend Per Share (TTM) - 1.8 % 0.06 % 192 % - -
Payout Ratio (TTM) - 31.62 % - 145.09 % - -
Growth
ASRT ZTS HLN TAK TEVA ITCI
Asset Growth -30.8 % -4.28 % -2.18 % 8.25 % - -3.51 %
Gross Profit Growth -9.05 % 3.7 % 5.84 % 1.76 % 5.47 % 88.3 %
Revenue Growth -2.67 % 5.74 % 4.09 % 5.87 % 4.4 % 86.4 %
Revenue 3 Year -47.2 % 31.98 % 13.9 % 33.13 % 1.52 % 1412.54 %
Revenue 5 Year -89.05 % 53.64 % 32.87 % 103.83 % -5.5 % -
Revenue 10 Year -77.37 % 103.1 % 32.87 % 152.69 % -38.45 % 2947.67 %
EBIT Growth -521.24 % 6.27 % 9.37 % -56.36 % -169.98 % 39.54 %
Net Income Growth -402.8 % 10.88 % -1.04 % -54.56 % -193.2 % 45.49 %
Net Income 3 Yeari Growth Per Share -335.19 % 47.55 % -8.67 % -61.74 % -482.97 % 54.85 %
Net Income 5 Yeari Growth Per Share -301.94 % 71.94 % 59.66 % 32.36 % -58.26 % 48.63 %
Net Income 10 Yeari Growth Per Share -253.04 % 404.24 % 59.66 % 35.42 % -140.46 % 6.62 %
Operating Income Growth -521.24 % 6.27 % 9.37 % -56.36 % -169.98 % 39.54 %
Operating Cash Flow Growth (CFG) -36.89 % 23.06 % 1.79 % -26.69 % -8.85 % 54.03 %
Operating 3 Year CFG 127.91 % 14.12 % 48.8 % -29.25 % 52.26 % 60.38 %
Operating 5 Year CFG -84.64 % 37.69 % 166.36 % 118.64 % 123.59 % 40.03 %
Operating 10 Year CFG 1.55 % 274.61 % 166.36 % 384.17 % -81.66 % 1.25 %
EPS Growth -300.43 % 12.64 % - -54.92 % -190 % 46.32 %
EPS Diluted Growth -332.34 % 12.92 % - -54.86 % -186 % 46.32 %
Book Value Per Share -59.54 % 15.25 % 1.35 % 13.54 % - -11.58 %
Share Holder 3 Year Equity Growth Per Share -8.28 % 36.7 % -36.6 % 40.38 % - -33.92 %
Share Holder 5 Year Equity Growth Per Share -85.94 % 139.55 % -39.41 % 41.33 % - 6.21 %
Share Holder 10 Year Equity Growth Per Share -79.95 % 476.36 % -39.41 % 195.14 % - 236.03 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 102.58 % -100 % -
Debt Growth -38.82 % -16.5 % -9.43 % 10.53 % - -15.48 %
Free Cash Flow Growth -37.47 % 22.25 % 1.67 % -31.4 % -11.05 % 54.06 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2024 31 Dec 2023
Profitability
ASRT ZTS HLN TAK TEVA ITCI
Gross Profit Margin TTM 61.85 % 69.85 % 60.68 % 54.74 % 48.74 % 92.29 %
Return on Assets TTM -24.81 % 17.46 % 3.26 % 1.38 % -4.17 % -6.52 %
Return on Equity TTM -51.19 % 49.65 % 6.54 % 2.83 % -26.15 % -9.93 %
Return on Capital Employed TTM -8.83 % 24.27 % 7.22 % 3.62 % -1.14 % -10.5 %
Net Income Per EBT TTM 160.45 % 79.35 % 65.38 % 89.75 % 127.75 % 101.45 %
EBT Per Ebit TTM 260.05 % 119.26 % 82.95 % 49.18 % 423.43 % 70 %
EBIT Per Revenue TTM -13.05 % 28.38 % 17.82 % 10.3 % -1.83 % -19.84 %
Cash Flow To Debt Ratio TTM 51.79 % 43.79 % - 22.2 % 6.9 % -351.01 %
Receivables Turnover TTM 2.8 7.03 5.27 6.23 5.41 4.21
Payables Turnover TTM 3.65 6.45 1.23 4.5 3.85 4.57
Inventory Turnover TTM 1.21 1.21 3.03 1.66 2.82 2.01
Fixed Asset Turnover TTM 7041.6 % 256.4 % 604.62 % 226.93 % 334.34 % 3826.92 %
Asset Turnover TTM 45.57 % 65.01 % 33.71 % 30.31 % 42.07 % 46.28 %
Operating Cash Flow Per Share TTM 0.22 6.5 - 678.77 1.1 -0.59
Free Cash Flow Per Share TTM 0.22 5.06 - 484.07 0.66 -0.59
Cash Per Share TTM 92.9 % 437.03 % 5.72 % 33271.95 % 291.26 % 951.67 %
Operating Cash Flow Sales Ratio TTM 16.35 % 31.9 % - 23.47 % 7.54 % -10.14 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.88 % 77.82 % - 71.32 % 60.06 % 101.21 %
Cash Flow Coverage Ratios TTM 51.79 % 43.79 % - 22.2 % 6.9 % -351.01 %
Price To Free Cash Flows Ratio TTM 3.74 31.27 - 8.65 25.35 -217.35
Price To Operating Cash Flows Ratio TTM 3.77 24.68 - 6.16 15.21 -218.82
Price Cash Flow Ratio TTM 3.77 24.68 - 6.16 15.21 -218.82
Income Statement (TTM)
ASRT ZTS HLN TAK TEVA ITCI
Revenue $0.15B $9.26B $11.3B $4263.76B $16.54B $0.68B
Gross Profit $0.13B $6.54B $6.96B $2832.26B $8.06B $0.62B
Gross Profit Ratio 82.23% 70.62% 61.59% 66.43% 48.74% 91.63%
EBITDA $-0.22B $3.86B $2.35B $874.6B $-0.3B $-0.12B
Net Income $-0.33B $2.49B $1.05B $144.07B $-1.64B $-0.07B
EPS Diluted -4.67 5.47 0.11 91.16 -1.45 -0.72
Balance Sheet (MRQ)
ASRT ZTS HLN TAK TEVA ITCI
Long Term Debt $0.04B $5.39B $8.8B $5029.93B $16.3B $0.01B
Total Liabilities $0.15B $9.47B $17.33B $7834.79B $33.61B $0.22B
Total Equity $0.14B $4.77B $16.73B $7274.01B $5.72B $1.15B
Total Investments $0B $0B $0.07B $445.7B $0B $0.69B
Total Debt $0.04B $6.74B $9.46B $4843.75B $18.08B $0.02B
Total Assets $0.29B $14.24B $34.06B $15108.79B $39.33B $1.37B
Cash Flow Statement (TTM)
ASRT ZTS HLN TAK TEVA ITCI
Net Income $-0.33B $2.5B $1.11B $144.07B $-1.96B $-0.07B
Inventory $-0B $-0.04B $-0.13B $-115.74B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-0.39B $-287.19B $0B $0B
Operating Cash Flow $0.05B $2.95B $2.1B $716.34B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-0.34B $-480.73B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.34
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.69
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 11.81
ALVOW Alvotech 2.3
AMPH Amphastar Pharmaceuticals, Inc. 31.97
AMRX Amneal Pharmaceuticals, Inc. 8.49
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 54.56
AQST Aquestive Therapeutics, Inc. 2.79
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 8.1
AYTU Aytu BioPharma, Inc. 1.29
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ASRT
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00431 215.39
VTI Vanguard Total Stock Market Index Fund 0 292.885
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00002 129.95
IWN iShares Russell 2000 Value ETF 0.00839 161.535
IWV iShares Russell 3000 ETF 0.00015 337.975
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 0.018 40.925
VXF Vanguard Extended Market Index Fund 0 187.56
HDG ProShares Hedge Replication ETF 0.000725824 49.94
SPTM SPDR Portfolio S&P 1500 Composite Stock Market ETF 0 72.26
UWM ProShares Ultra Russell2000 0.00145404 39.265
VTHR Vanguard Russell 3000 Index Fund 0 262.915
IWC iShares Micro-Cap ETF 0.02703 122.56
DWAS Invesco DWA SmallCap Momentum ETF 1.223 84.34
URTY ProShares UltraPro Russell2000 0.000690219 44.225
VTWV Vanguard Russell 2000 Value Index Fund 0.01 142.21
EES WisdomTree U.S. SmallCap Earnings Fund 0.0002433 52.74
FDM First Trust Dow Jones Select MicroCap Index Fund 0.17 68.85
FLQS Franklin LibertyQ U.S. Small Cap Equity ETF 0 41.39
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 67.5
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.054 39.37
VFMO Vanguard U.S. Momentum Factor ETF 0.05 163.13
VTWO Vanguard Russell 2000 Index Fund 0 87.075
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.32 30.95
PZW.TO Invesco FTSE RAFI Global Small-Mid ETF 0.0089 36.02
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 100.69
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 100.67
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.28
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.27
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.27
ROSC Hartford Multifactor Small Cap ETF 0.092521 42.65
RYLD Global X Russell 2000 Covered Call ETF 0 16.075
AVUV Avantis U.S. Small Cap Value ETF 0.06 93.16
AVUS Avantis U.S. Equity ETF 0 98.17
VTSAX Vanguard Total Stock Market Index Fund 0 143.29
AVSU Avantis Responsible U.S. Equity ETF 0.01 66.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.42
VITSX Vanguard Total Stock Market Index Fund 0 143.31
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000170977 100.68
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.42
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00343662 34.93
AVSC Avantis U.S. Small Cap Equity ETF 0.03 52.68
VEMPX Vanguard Extended Market Index InstlPlus 0 353.93
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 268.83
RSSL Global X Funds 0 84.665
RFLR Innovator ETFs Trust 0.01 25.09
Unlock